These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27864824)

  • 1. Successful treatment of ustekinumab in a psoriasis patient with human T-cell leukemia/lymphotropic virus type 1 infection.
    Kazama M; Umezawa Y; Itoh M; Nobeyama Y; Ito T; Kikuchi S; Yanaba K; Asahina A; Nakagawa H; Ogasawara Y
    J Dermatol; 2017 Nov; 44(11):1334-1335. PubMed ID: 27864824
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of ustekinumab in a severe psoriasis patient with human immunodeficiency virus infection.
    Saeki H; Ito T; Hayashi M; Fukuchi O; Umezawa Y; Nobeyama Y; Teruya K; Nakagawa H
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1653-5. PubMed ID: 24754476
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful ustekinumab treatment in a patient with psoriasis and subacute cutaneous lupus erythematosus.
    Mazgaj M; Picard-Dahan C; Deschamps L; Marinho E; Estève E; Descamps V
    Int J Dermatol; 2020 Apr; 59(4):e118-e120. PubMed ID: 31957866
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy.
    Fujita Y; Shinkuma S; Nomura T; Shimizu H
    Eur J Dermatol; 2016 Apr; 26(2):187-8. PubMed ID: 26643260
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
    Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
    J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
    [No Abstract]   [Full Text] [Related]  

  • 6. Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab.
    Goh SW; Jamil A; Nor NM; Cader RA; Shaharir SS
    Indian J Dermatol Venereol Leprol; 2020; 86(1):68-70. PubMed ID: 31823905
    [No Abstract]   [Full Text] [Related]  

  • 7. A successful treatment with ustekinumab in a case of relapsing bullous pemphigoid associated with psoriasis.
    Loget J; Plée J; Antonicelli F; Bernard P
    J Eur Acad Dermatol Venereol; 2017 May; 31(5):e228-e230. PubMed ID: 27730667
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety of ustekinumab in severe psoriasis with chronic hepatitis B.
    Raymundo AR; Facin AP; Silva de Castro CC; Faria AR
    Indian J Dermatol Venereol Leprol; 2016; 82(3):326-8. PubMed ID: 27088944
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of psoriasis and psoriatic arthritis with secukinumab after unsatisfactory response to ustekinumab in multiple sclerosis patient.
    Assefa GT; Kaneko S; Oguro H; Morita E
    J Dermatol; 2019 Mar; 46(3):e112-e113. PubMed ID: 30151838
    [No Abstract]   [Full Text] [Related]  

  • 10. Determination of the Nail Psoriasis Severity Index improvement rate standards for nail psoriasis treatment in a phase IV clinical trial of ustekinumab: the MARCOPOLO study.
    Youn SW; Kim BR; Cho S; Seo SJ; Lee ES; Roh JY; Choi GS; Lee MG;
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e298-e299. PubMed ID: 27976465
    [No Abstract]   [Full Text] [Related]  

  • 11. Psoriasis-associated interstitial pneumonia.
    Hara H; Kuwano K; Kawamoto H; Nakagawa H
    Eur J Dermatol; 2018 Jun; 28(3):395-396. PubMed ID: 29521628
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.
    Mugheddu C; Atzori L; Del Piano M; Lappi A; Pau M; Murgia S; Zucca I; Rongioletti F
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28833973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ustekinumab treatment in patients with psoriasis undergoing hemodialysis.
    Umezawa Y; Hayashi M; Kikuchi S; Fukuchi O; Yanaba K; Ito T; Asahina A; Saeki H; Nakagawa H
    J Dermatol; 2015 Jul; 42(7):731-4. PubMed ID: 25959602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of annular pustular psoriasis with ustekinumab.
    Schnabel V; Broekaert SMC; Schön MP; Mössner R
    Eur J Dermatol; 2017 Jun; 27(3):296-297. PubMed ID: 28202422
    [No Abstract]   [Full Text] [Related]  

  • 15. Five-year experience with Ustekinumab for psoriasis: real-life data of a single centre.
    Vergou T; Moustou AE; Antoniou C
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):e40-e41. PubMed ID: 27038363
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of psoriasis and systemic lupus erythematous successfully treated with ustekinumab.
    Nogueira M; Selores M; Torres T
    Eur J Dermatol; 2021 Jun; 31(3):429-431. PubMed ID: 34309535
    [No Abstract]   [Full Text] [Related]  

  • 17. Case of psoriatic patient who maintains long-term remission after anti-hepatitis C virus agents and ustekinumab treatment.
    Kikuchi S; Umezawa Y; Chihara M; Asahina A; Nakagawa H
    J Dermatol; 2018 Mar; 45(3):e59-e60. PubMed ID: 29388245
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of chronic disseminated lupus erythematosus in a psoriatic patient receiving ustekinumab.
    Moretta G; Caldarola G; Potenza A; Peris K; De Simone C
    G Ital Dermatol Venereol; 2020 Oct; 155(5):699-701. PubMed ID: 30428653
    [No Abstract]   [Full Text] [Related]  

  • 19. Inadvertent pregnancy during ustekinumab therapy in a patient with plaque psoriasis and impetigo herpetiformis.
    Alsenaid A; Prinz JC
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):488-90. PubMed ID: 25413895
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of ustekinumab in palmoplantar pustulosis.
    Hegazy S; Konstantinou MP; Bulai Livideanu C; Tauber M; Uthurriague C; Paul C
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):e204-e206. PubMed ID: 29194805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.